Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...

Kingsview Wealth Management LLC raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 16.5% in the fourth quarter, according to the company in its most recent ...

In a report released on February 7, Cory Kasimov from Evercore ISI maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing mounting ... a significant drop in its stock price on October 31, 2024.

(MENAFN- GlobeNewsWire - Nasdaq) SAN FRANCISCO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. ( NASDAQ: REGN ) is facing ... drop in its stock price on October 31, 2024.

Riley Securities also downgraded Skyworks to Neutral from Buy, while Mizuho downgraded the stock to Neutral from ... Underperform rating but upped the price target to $60 from $28.

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Current price $690.36 52-week high $1,211.20 ...